Kanwardeep Singh

Kanwardeep Singh

Auto-generated profile, based on publicly available information

Kanwardeep Singh

Department of Microbiology, Government Medical College, Amritsar, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in International Journal of Contemporary Medical Research [IJCMR]
Verified
Journal Article
Open access
ACAkanksha Chopra
Akanksha Chopra
KSKanwardeep Singh
Kanwardeep Singh
SSShailpreet Sidhu
Shailpreet Sidhu
LOLoveena Oberoi
Loveena Oberoi
AKArpandeep Kaur
Arpandeep Kaur

30 September 2022 in Korean Journal of Clinical Laboratory Science
Verified
Journal Article
Open access
PDF file
AKAmandeep Kaur
Amandeep Kaur
NSNarinder Singh
Narinder Singh
KSKanwardeep Singh
Kanwardeep Singh
SSShailpreet Kaur Sidhu
Shailpreet Kaur Sidhu
HKHarleen Kaur
Harleen Kaur
MJMohan Jairath
Mohan Jairath

29 January 2022 in International Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
JKJaspal - Kaur
Jaspal - Kaur
LOLoveena Oberoi
Loveena Oberoi
KSKanwardeep Singh
Kanwardeep Singh
RCRakesh Chander
Rakesh Chander
Background: Hepatitis C is an emerging infectious disease all over the world especially in the developing countries. HCV is a blood borne virus, well known risk factors include blood transfusion, injection drug abuse, chronic haemodialysis patients. HCV is a single stranded positive sense RNA virus, belongs to family flaviviridae and genus Hepacivirus. Haemodialysis patients are the high risk group due to prolonged vascular access and contaminated equipments. Methods: The present study was retrospective conducted from June 2019 to 31 July 2020 in the Department of Microbiology, Government Medical College, Amritsar. Clinical, demographic and geographical data of the renal disease patients admitted to the hospital for haemodialysis was recorded and analysed. The patients were tested for HCV by Third Generation ELISA. Results: In the present study, out of enrolled 186 patients, 12 were HCV positive (0.06%). Prevalence of Hepatitis C infection in haemodialysis patients is associated with gender distribution more in females (72%) than males (62%), preponderance of HCV infection was observed in age group 41-60 years (69%) followed by 21-40 years (23%),more rural (85%) distribution. Diabetes (19%), hypertension (25%) and chronic kidney disease (63%) were the associated comorbid conditions. Conclusions: The overall HCV sero prevalence was observed to be 0.06%, this low prevalence can be attributed to the fact that increased awareness regarding the disinfection of dialysis machines by improving the surveillance system of HCV and better education of nurses in dialysis units. HD patients should be routinely screened for HCV infection.